This site uses cookies to bring you the best experience. Find out more
Skip to main content

SECURITIES INFORMATION

 

NUMBER OF AIM SECURITIES IN ISSUE

As of 3 January 2024, the number of shares in issue was 533,352,523.

SIGNIFICANT SHAREHOLDERS

As of 3 January 2024 significant shareholdings in the share capital of Eden Research plc were:

Name

Number of shares

% of the issued ordinary share capital

Hargreaves Lansdown

 

53,364,313

10.01%

Gresham House Asset Management Limited

 

52,882,786

9.92%

Octopus Investments

 

41,551,047

7.79%

Sipcam Oxon S.p.A.

 

39,285,138

 

7.37%

 

Interactive Investor

 

33,363,457

 

6.26%

 

Canaccord Genuity Wealth Management

 

30,276,307

5.68%

Unicorn Asset Management

 

23,076,923

4.33%

Rathbones 

 

23,040,287

4.32%

Atul Unadkat

 

22,099,924

4.14%

JM Finn Nominees Limited

 

20,147,562

3.78%

Amati Global Investors

 

16,744,070

3.14%

BGF Investment Management Limited

 

16,000,576

3.00%

 

Name

Number of shares

% of the issued ordinary share capital

A Abrey                                                                 

 

1,774,192

0.33%

L van der Broek

 

1,621,808

0.30%

S Smith

 

1,192,577

0.22%

R Cridland

 

745,552

0.14%

R Horsman

 

475,000

0.09%

 

SHARES NOT IN PUBLIC HANDS

In the terms of AIM Rules published July 2016 and insofar as it is aware, at 3 January 2024, 18.37% of the Company's AIM securities was not in public hands.

RESTRICTION IN TRANSFER OF AIM SECURITIES

There are no restrictions on the transfer of Eden Research Plc's AIM securities.

DETAILS OF ANY OTHER EXCHANGES AND TRADING PLATFORMS

Eden Research Plc has not applied or agreed to have any of it securities (including its AIM securities) admitted or traded on any other exchanges or trading platforms.

UK CITY CODE ON TAKEOVERS AND MERGERS

As an AIM traded UK registered company, Eden Research plc is subject to the UK City Code on Takeovers and Mergers legislation.